Selective estrogen receptor modulators: Clinical spectrum

被引：199

作者：

Cosman, F ^{[1
]}

Lindsay, R

机构：

[1] Helen Hayes Hosp, Reg Bone Ctr, New York State Dept Hlth, W Haverstraw, NY 10993 USA

[2] Helen Hayes Hosp, Clin Res Ctr, New York State Dept Hlth, W Haverstraw, NY 10993 USA

来源：

关键词：

D O I：

10.1210/er.20.3.418

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：418 / 434

页数：17

共 186 条

[1] ABE O, 1991, AM J CLIN ONCOL-CANC, V14, pS40
[2] ALBAIN K, 1997, P AN M AM SOC CLIN, V16, pA128
[3] ENDOCRINE EFFECTS OF THE COMBINATION OF MEGESTROL-ACETATE AND TAMOXIFEN IN THE TREATMENT OF METASTATIC BREAST-CANCER
ALEXIEVAFIGUSCH, J
BLANKENSTEIN, MA
DEJONG, FH
LAMBERTS, SWJ
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (09): : 1135 - 1140
[4] CARCINOGENIC EFFECTS OF ADJUVANT TAMOXIFEN TREATMENT AND RADIOTHERAPY FOR EARLY BREAST-CANCER
ANDERSSON, M
STORM, HH
MOURIDSEN, HT
[J]. ACTA ONCOLOGICA, 1992, 31 (02) : 259 - 263
[5] [Anonymous], 1992, Lancet, V339, P1
[6] [Anonymous], [No title captured]
[7] ASHFORD AR, 1988, CANCER, V61, P33, DOI 10.1002/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO
[8] 2-I
[9] AUGER MJ, 1988, CANCER, V61, P1316, DOI 10.1002/1097-0142(19880401)61:7<1316::AID-CNCR2820610707>3.0.CO
[10] 2-5